Tyenne (tocilizumab-aazg) Injection Recall: What To Do

Fresenius Kabi recall news reached patients and providers in early September 2026. On September 2, 2026, the U.S. Food and Drug Administration listed a Class I recall of Tyenne (tocilizumab-aazg) Injection. The company is Fresenius Kabi USA, LLC, of Lake Zurich, Illinois. An internal investigation at the firm found glass particles in the product. Class I is the most serious recall category the FDA uses. As a result, anyone who receives this infused medicine should understand what the recall covers.

This guide explains the product, the hazard, and practical next steps. It also covers what a recall does and does not mean legally. We treat the FDA’s record as the source of truth throughout.

What the Fresenius Kabi Recall Covers

This fresenius kabi recall involves a single product listing. It is Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL. That works out to 20 mg per milliliter. The product comes in a 20 mL vial. The label reads “Rx Only,” so a prescription is required. The National Drug Code, or NDC, is 65219-594-20.

The FDA record lists 4,643 units in scope. However, the agency data we reviewed does not list specific lot numbers or expiration dates. It also does not say where the product was shipped. For that reason, we will not guess at those details. The official FDA notice is the best place to confirm lot and distribution information.

Tyenne is a biosimilar to Actemra, which is also a tocilizumab product. A biosimilar is a biologic drug that is highly similar to an approved reference product. Typically, tocilizumab is used to treat certain autoimmune and inflammatory conditions. Rheumatoid arthritis is one common example. Doctors prescribe it, and trained staff usually give it by intravenous infusion.

In most cases, patients do not keep these vials at home. The drug is typically stored and prepared at a hospital, clinic, or infusion center. However, patients still have a real stake in this recall. If you received a Tyenne infusion recently, you may want to ask your care team about it.

The Hazard and Reported Injuries

The FDA record describes the problem as “presence of particulate matter.” Specifically, an internal investigation at the firm found glass particles in the product. Injectable drugs are supposed to be sterile and free of visible particles. Glass should never be present in a vial meant for the bloodstream.

Why does this matter? In general, particles in an injected drug can cause harm. For example, they may irritate or inflame the blood vessels. They may also trigger local swelling or an immune reaction. In more serious cases, particles can travel and block small blood vessels. These are general risks of particulate matter. They are not findings about any specific patient.

The FDA classified this fresenius kabi recall as Class I. That is the agency’s most serious category. It means there is a reasonable probability that use could cause serious health problems or death. However, the classification describes potential risk. It does not, by itself, confirm that anyone was harmed.

The agency record does not state whether any injuries have been reported. We will not claim either way. If new information emerges, the FDA typically updates its enforcement reports. The key facts from the official record are summarized below.

What To Do If You Own This Product

Most readers will not “own” this drug in the usual sense. However, clinics, pharmacies, and some patients may have it on hand. The first step is simple. Do not use any vial that matches this fresenius kabi recall until you confirm its status.

Next, identify the product. Check the carton and vial label for the name Tyenne (tocilizumab-aazg). Look for the strength of 400 mg/20 mL. Then compare the NDC number, 65219-594-20. Also write down any lot number and expiration date printed on the label. Those details help your pharmacist or provider check the official notice.

The agency record for this fresenius kabi recall contains remedy text that does not match the product. As a result, we have withheld it. We will not tell you what the remedy is. Instead, follow the instructions in the official notice, available through the
FDA Enforcement Report database
. Your pharmacy or infusion center can also help you read it.

Patients should talk to their prescribing doctor before making any changes. Do not stop a prescribed therapy on your own. Your doctor can discuss timing, alternatives, or replacement supply. If you notice new symptoms after an infusion, seek medical care promptly. You can also report side effects through the
FDA MedWatch program
.

Does a Fresenius Kabi Recall Mean You Can Sue?

Here is the plain answer. A recall is not a lawsuit. A recall is a safety action taken by a company, often with FDA oversight. Its goal is to remove a risky product from use. It does not decide who is at fault. It also does not pay anyone.

This fresenius kabi recall alone does not create a legal claim. We have not verified any lawsuit filed over this recall. Typically, a product liability claim requires more than a recall notice. You generally need a real, documented injury. You also need evidence that the product caused that injury. Lawyers call that link causation.

For example, suppose a patient received a recalled vial and later developed a documented medical problem. A lawyer might review medical records, lot numbers, and infusion dates. However, every case depends on its own facts. Many people who receive a recalled product never experience any injury at all.

If you believe you were harmed, consider speaking with a licensed attorney. Many product liability lawyers offer free consultations. Depending on the facts, you may be eligible to pursue a claim. No one can guarantee an outcome. Also, legal deadlines called statutes of limitations vary by state. Keep your records organized in the meantime.

How Recalls Connect to Mass Tort Cases

A recall can become important evidence in later litigation. It can show when a company learned of a defect. It can also show how widespread a problem was. For example, Philips recalled millions of CPAP and ventilator devices in 2021. The concern was sound-reducing foam that could break down. Lawsuits followed and were consolidated in federal court in Pennsylvania.

Takata airbags offer another example. Defective inflators could rupture and send metal fragments toward drivers and passengers. The recall became one of the largest in U.S. automotive history. Related litigation was consolidated in federal court in Florida. In both cases, the recall itself did not resolve anything. Instead, it became one piece of the evidence.

In drug cases, other records often matter too. Typically, these include FDA inspection reports, manufacturing records, and internal company documents. Courts weigh that evidence alongside each plaintiff’s medical history. As a result, litigation can take years to develop.

Not every recall leads to a mass tort. In most cases, litigation grows only when many people report similar injuries. Whether that happens with this fresenius kabi recall is unknown. For now, the best step is to stay informed and follow medical advice.

Frequently Asked Questions

What product is part of the Fresenius Kabi recall?

The recall covers Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL, in a 20 mL vial. The NDC is 65219-594-20. The FDA record lists 4,643 units in scope.

Why is this fresenius kabi recall rated Class I?

An internal investigation at the firm found glass particles in the product. Class I is the FDA’s most serious category. It signals a reasonable probability of serious health consequences, though it does not confirm injuries.

Is there a lawsuit over the fresenius kabi recall?

We have not verified any lawsuit tied to this recall. A recall is a safety action, not a lawsuit. If you believe you were harmed, a licensed attorney can review whether you may be eligible to file a claim.

Were You Injured by a Recalled Product?

A recall by itself is a safety action, not a legal claim. However, if a recalled product caused a real injury, you may be eligible to pursue compensation. A licensed attorney can review your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover.

Official Sources & Resources

Verify every recall against the issuing agency before acting:

• U.S. Food and Drug Administration: official recall database — the record of truth for this notice
• CPSC: cpsc.gov — household goods, toys, furniture, appliances
• FDA: fda.gov — food, drugs, and medical devices
• NHTSA: nhtsa.gov — vehicles, tires, and child car seats
• USDA FSIS: fsis.usda.gov — meat, poultry, and egg products

Content last reviewed September 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

• All Product Recalls
• All Active MDL Cases
• Mass Tort Explainers
• Mass Tort Tips
• Tort Reform by State — 50-State Comparison

Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. A product recall is a safety action by a manufacturer or regulator and does not by itself establish liability or create a legal claim. No attorney-client relationship is created by accessing or using this content. Every case is unique. If you believe you were harmed by a recalled product, consult a licensed attorney in your jurisdiction.